Exelixis Cabometyx, Pfizer Sutent Compete In Kidney Cancer Clinical Trial Cabozantinib was found to improve progression-free survival in metastatic renal cell carcinoma. A clinical study for the treatment of metastatic kidney cancer suggested cabozantinib will potentially become a first-line treatment. by Livia Rusu
Healthy Living/Wellness Nutrient Deprivation Can Effectively Kill Kidney Cancer Cells, Study Finds by Katherine Derla
Healthy Living/Wellness Cooking Meat At High Temperatures Increases Kidney Cancer Risk by Katrina Pascual
Healthy Living/Wellness Opdivo And Cometriq Drugs Proven More Effective Than Novartis' Afinitor As Advanced Kidney Cancer Treatment by Rhodi Lee
Healthy Living/Wellness Teen's Bleeding Nose Leads To Diagnosis Of Dangerous Disease: 3 Lives Saved By Diagnosis by Rina Marie Doctor
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband